Showing posts with label Generic drugs. Show all posts
Showing posts with label Generic drugs. Show all posts

Tuesday, June 25, 2019

Doctors to dispense generic drugs only



As per the minutes of the 56th Meeting of Drugs Consultative Committee held on 1st JUNE, 2019 at New Delhi, agenda 4, one the proposed amendments has been done in the Drugs and Cosmetic Rules 1945 and medical practitioners will not be able to dispense branded drugs to their patient. The amendment is to prevent misuse of the exemption, which allows them to be out of the schedule H, exemption from procuring a license to dispense the medicine.

“CONSIDERATION OF THE PROPOSAL FOR AMENDMENT OF THE EXEMPTIONS PROVIDED UNDER SCHEDULE K REGARDING SUPPLYING OF MEDICINES BY REGISTERED MEDICAL PRACTITIONERS TO THEIR PATIENTS

DCC was apprised that Registered Medical Practitioners (RMP) can supply different categories of medicines including vaccines to their patients as per the exemption provided with certain conditions under Schedule K of the Drugs and Cosmetics Rules, 1945.

Currently, there is no specific category which can be supplied by RMP to their patients. It is proposed that the following additional conditions may be incorporated under the conditions of exemption to prevent the misuse of the exemption:

1. The Registered Medical Practitioner shall supply generic medicines only.
2. The Registered Medical Practitioners shall supply the ‘Physicians Samples’ at free of cost.

DCC deliberated the proposal and agreed to amend Schedule K of the Drugs and Cosmetics Rules, 1945 to specify the medicines to be supplied by RMP to their patients.”

Appropriate MCI provisions

3.7.1 A physician shall clearly display his fees and other charges on the board of his chamber and/or the hospitals he is visiting. Prescription should also make clear if the Physician himself dispensed any medicine.


6.5 Secret Remedies: The prescribing or dispensing by a physician of secret remedial agents of which he does not know the composition, or the manufacture or promotion of their use is unethical and as such prohibited. All the drugs prescribed by a physician should always carry a proprietary formula and clear name.

6.3 Running an open shop (Dispensing of Drugs and Appliances by Physicians): - A physician should not run an open shop for sale of medicine for dispensing prescriptions prescribed by doctors other than himself or for sale of medical or surgical appliances. It is not unethical for a physician to prescribe or supply drugs, remedies or appliances as long as there is no exploitation of the patient. Drugs prescribed by a physician or brought from the market for a patient should explicitly state the proprietary formulae as well as generic name of the drug.

Drugs and Cosmetic Rules Schedule K(5): Drugs supplied by a registered medical practitioner to his own patient or any drug specified in Schedule C supplied by a registered medical practitioner at the request of another such practitioner if it is specially prepared with reference to the condition and for the use of an individual patient provided the registered medical practitioner is not (a) keeping an open shop or (b) selling across the counter or (c) engaged in the importation, manufacture, distribution or sale of drugs in India to a degree which render him liable to the provisions of Chapter IV of the Act and the rules thereunder.

All the provisions of Chapter IV of the Act and the Rules made thereunder, subject to the following conditions:
5[(1)The drugs shall be purchased only from a dealer or a manufacturer licensed under these rules and records of such purchases showing the names and quantities of such drugs together with their batch numbers and the names and addresses of the manufacturers shall be maintained. Such records shall be open to inspection by an Inspector appointed under the Act, who may, if necessary, make enquiries about purchases of the drugs and may also take samples for test.

(2) In the case of medicine containing a substance specified in 1 [Schedule G, H or X] the following additional conditions shall be complied with]:

(a) the medicine shall be labelled with the name and address of the registered medical practitioner by whom it is supplied;

(b) if the medicine is for external application, it shall be labelled with the words  “For external use only” or if it is for internal use with the dose;

(c) the name of the medicine or ingredients of the preparation and the quantities thereof, the dose prescribed, the name of the patient and the date of supply and the name of the person who gave the prescription shall be entered at the time of supply in register to be maintained for the purpose;

(d) the entry in the register shall be given a number and that number shall be entered on the label of the container;

(e) the register and the prescription, if any, on which the medicines are issued shall be preserved for not less than two years from the date of the last entry in the register or the date of the prescription, as the case may be.

3[(3)The drug will be stored under proper storage conditions as directed on the label.

Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA

Friday, February 22, 2013

Health Sector is demanding and is not a 9 to 5 Job: P K Pradhan



In an interaction with IMAS, Sh P K Pradhan Former Health Secretary Govt. of India said that MCI should be reconstituted this year, reports Padma Shri and Dr B C Roy National Awardee Dr K K Aggarwal National Vice President Elect IMA.

The interaction was held on Wednesday at IMA 20th Feb IMA hall and was moderated by Dr Narender Saini Secretary General IMA. I too was present at this interaction.

Other present were Dr D R Rai, Dr Atul Arora, Dr   S Roy, Dr V K Narang, Dr Ajay Gambhir, Dr Ghulam Abbas Zaidi and Dr Zainab Zaidi.
Following is the gist of the interaction.

About the health budget
1.      Government of India under NRHM and other schemes gives 75% grants to the States and 25% has to be raised by them. Many states are not being able to utilize the funds quickly and avail their grant in full.  Bihar has come up very well in healthcare infrastructure during last few years. Performances as well as health care in UP, Chhatisgarh and Jharkhand are still a matter of concern.
2. When it comes to release of funds under health schemes, the releases are made purely on performance and no other considerations. If money is not used by the states, it is due to lack of performance and inefficiency. There are no political considerations.
3.    Many States like Madhya Pradesh, Orissa, Tamil Nadu, Karnataka, Haryana, Himachal Pradesh, J & K and Rajasthan were provided additional funds under NRHM during the last few years.
4.  Most of the Plan budget of the States, even up to 80%, goes towards salaries.

About health infrastructure in different states
1.      Tamil Nadu health services are one of the best in the country. Health care is available at the lowest cost.  Governance is a good factor for implementation of healthcare services. Assam, Madhya Pradesh, Rajasthan and Orissa among the high focus states have picked up very well. Andhra Pradesh needs to improve the primary healthcare system.  
2.      The quality of services in medical colleges needs to improve substantially. In some of the district hospitals, the care may be better than medical colleges as senior doctors in medical colleges are often busy in private practice.

About vacant posts at rural setups
Wherever medical officer posts are to be filled by state PSCs, there is considerable delay. Many States have started doing selection directly to overcome this problem and to place doctors in position.

 IMA image
1.      It is not correct that IMA has an image of anti-governance.
2.      It is only that IMA representatives and documentation do not reach the right people in the right time.
3.      In the eyes of the government, IMA is at a high standing image.
4.     Since IMA is taking up various projects, it should build a stronger partnership with Government both at the Center as well as State level to build capacity and improve the health care in the country.

About MCI
As things stand, Medical Council of India should be reconstituted after the term of the present BoG is over. There is need for two amendments in its old format.
1. One will not be able serve for more than two terms.
2.  More representation from state health science universities where there are a large no. of medical colleges.

About Dr B C Roy Awards
Dr. BC Roy Awards issue needs to be raised with the Medical Council of India.

About Capacity building and BSc community health courses
1. Everybody in the hospital, from ward boy, person doing waste disposal and other service providers need to be skilled and can be provided six months courses by accredited institutions.
2.  The need is to constitute a paramedical council. IMA can facilitate this, prepare a draft and approach the health ministry.
3. The Government today is proposing BSC Community Health Programme to create mid level health providers who can be groomed as public health personnel.
4. IMA point of view is that MCI or DNB should not develop the curriculum and become an accredited institution to impart such courses and register them. Government however is envisaging the same as there is no council at the moment available for the same. The government is choosing them on the philosophy unless you register you cannot be de-registered. IMA feels that a separate paramedical council should be made to recognise them.  
5. A community health worker will provide better preventive health care than an ANM.
6.  The introduction of the courses will depend on States. It is possible that southern and western States may not go for BSC Community Health Courses.
7.  The BSc Community Health workers will be required more in the remote rural areas to strengthen the public health and where it takes more than few hours to reach for primary care.
8. IMA approved paramedical courses can be recognized by states and the centre.

About public health
1.   Non-doctors should also be allowed to become public health professional.
2.   The burden of diabetes, old age problem and mental health are going to assume very high proportion in the coming years and it is time be fully prepared to cope with the situation.

About IMA as NGO
IMA can think of building dialyses centers and blood banks in different district and can approach State Govt. and Center for support.  The government is planning to have diagnostic centre in each district hospitals.

About Generic Drugs
The MRP of drugs is not controlled by the government. Government is trying to regulate prices of only essential drugs.

About Medical colleges
Several reforms have been undertaken to facilitate setting up new medical colleges and augment both UG and PG seats. This includes rationalization of land and infrastructure requirements, having colleges in two campuses etc. The no. of seats should go up substantially now.

What about an offer to be a friend of IMA
I can support activities of IMA to improve health care in the country as “Friends of IMA”.

Requirement of Health Sector
1.      Health sector is extremely complex, demanding and is not a 10 to 5 job.
2.      It requires passion and commitment to work for long hours.

Wednesday, February 6, 2013

Generic drugs vs patented drugs vs branded drugs vs generic names of the drugs

Medical Council of India Code of Medical ethics: 1.5 Use of Generic names of drugs: Every physician should, as far as possible, prescribe drugs with generic names and he / she shall ensure that there is a rational prescription and use of drugs.
Interpretation
1.   Use of Generic names of drugs: it’s not use of generic drugs
2.   Every physician should: the word SHOULD makes it a binding
3.   As far as possible means to the best of his or her capacity
4.   Prescribe drugs with generic names:  is not same as prescribing generic drugs. It only means the name of the salt should also be written. 
5.   Shall ensure that there is a rational prescription: Rational means prescription of drugs which are evidence based and or with informed consent. 
6.    Rational use of drugs: means same when dispensing.
Thus Medical Council of India says “prescribe drugs with their generic names” which makes sense as what they insist is that as far as possible we should write the name of the salt also. By writing the name of the salt one will be able to avoid lot of prescription errors and will be able to do and prescribe drugs rationally. For example instead of writing Stamla 5 mg once daily at night one should write AMLODIPINE (STAMLO) 5Mg a bed time.

What is the difference between a patented and a generic drug
1.PATENT DRUG means a drug belonging to the original company who has researched the pharmaceutical molecule. The company will have rights of that molecule for ten years. During these ten years, no other company can manufacture and sell this compound. After ten years, the patent finishes then any company can copy or modify the molecule and come out with its own brands.
2. After the patent is over the patent drug becomes a GENERIC DRUG.
3. Brand means any drug which is marketed by a company specific name. Both patented and generic drugs can have a brand name. Brand names are so designed so that a person can easily remember the drug, or its action
4. The word GENERIC NAME means the original salt name of the compound. It is not same as generic drug.
5. A drug can be sold under any of the three categories: Under the name of the generic salt (no brand name), unpopular brand name and a popular brand name. The same company usually sells them under all three categories. Under the salt name they sell in a supply of 100 or more; under unpopular brand name they pitch for an institutional bulk supply and under popular brand name they market for individual doctor’s prescription. The cost of the generic salt will obviously be cheaper. 
6. Actually almost all the drugs produced in India are GENERIC DRUGS (generic equivalents) under different BRAND NAMES. The prises of them may vary and are not controlled by the doctors. MRP is decided and permitted by the government.
7. In USA BRAND is the name given to the patented drug. After ten years the sane drug is sold as generic equivalent.

How to reduce the cost of the drugs being prescribed
1. One can write AMLODIPINE (Dr Reddys lab) instead of a known brand. In that case the chemist should give the unbranded version of the drug which will be cheaper.
2.The government should ensure availability of unbranded drugs with generic name.
3.  The reimbursement policy should be to reimburse the cheapest drug (branded or unbranded with generic name version). If a person wants a costlier brand he or she should be allowed to pay the difference.
4.  For example, there are three types of stents in India -  the Drug Controller of India approved stents, the European approved stents and American approved stents with Indian stents being the cheapest and the American the costliest. If the Government reimburses all three of them, most of the patients and doctors will opt for the costlier American stents. The Government should reimburse only for the cheapest stents and anybody who wants an American stents should pay the difference.
5. Similarly, the insurance companies, public sector undertakings, CGHS and related agencies should reimburse for the cheapest drugs and devices. But will be policy makers and the politicians allow that because they are the ones who will opt for costly branded drugs or devices.
6.  Quite often it is argued that the drugs differ in efficacy and bioavailability. That is the difficult to understand as if a drug is approved by the Drug Controller of India, its efficacy should not be a matter of concern or challenge.
 7.  There are also arguments that drug licenses are a State subject and the reliability of a state licensed drug may be under question mark.
Conclusions
I personally feel that ever doctor should write a brand with the name of the generic salt in the bracket so that prescription errors goes to minimum.
Also the Drug Controller of India should release a website where every doctor should be able to find out which drugs are cheapest in the market and yet approved by the Drug Controller of India.

Padma Shri and Dr B C Roy National Awardee and National Vice President Elect India Medical Association